Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid–Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER

IMPORTANCE: Gout is common in patients with heart failure (HF), and sodium-glucose cotransporter 2 inhibitors, a foundational treatment for HF, reduce uric acid levels. OBJECTIVE: To examine the reported prevalence of gout at baseline, the association between gout and clinical outcomes, and the effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Jawad H., Docherty, Kieran F., Claggett, Brian L., Desai, Akshay S., Petersson, Magnus, Langkilde, Anna Maria, de Boer, Rudolf A., Hernandez, Adrian F., Inzucchi, Silvio E., Kosiborod, Mikhail N., Køber, Lars, Lam, Carolyn S. P., Martinez, Felipe A., Ponikowski, Piotr, Sabatine, Marc S., Shah, Sanjiv J., Vaduganathan, Muthiah, Jhund, Pardeep S., Solomon, Scott D., McMurray, John J. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947801/
https://www.ncbi.nlm.nih.gov/pubmed/36811901
http://dx.doi.org/10.1001/jamacardio.2022.5608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947801/
https://www.ncbi.nlm.nih.gov/pubmed/36811901
http://dx.doi.org/10.1001/jamacardio.2022.5608

Ejemplares similares